Alejandro Osorio, managing director of Grab Vietnam, speaks to VIR's Linh Le about the key milestones achieved over the last decade and the company's future vision in Vietnam.
Journalist Vir Sanghvi on Saturday criticised Tata Group-owned Air India after the airline downgraded his cabin class on an upcoming flight, saying he has "lost count of the number of times" the ...
Pham Duc Toan, consulting manager at Vietnam Investment Consulting, spoke with VIR’s Kim Oanh about the current situation involving these markets. What is your assessment about the investment ...
Fidelis is a private insurance company that offers Medicare Advantage plans in the state of New York. These plans offer extra benefits like vision and hearing, vision, and dental. Medicare ...
Vir Biotechnology's recent share price rally is driven by their promising cancer program, despite their primary focus on hepatitis management. The company's market cap has surged past $1 billion ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results